NovoCure (NVCR) Stock Faces Ongoing Losses As Q2 2026 EPS Narrows To $0.13 LossSimplywall·2 days ago, 08:03 PMNVCR-11.71%
NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Slidingbenzinga_article·2 days ago, 10:08 AMNVCR-11.71%
FY2029 EPS Estimates for NovoCure Decreased by HC WainwrightMarket Beat·Jul 24 at 06:42 AMNVCR-11.71%
Biotech Stocks At 52-Week Highs - MEDP And NVCR Rise With Positive Q2 Reports, ETON, MRVI, ADVBrttnews·Jul 24 at 05:31 AMETON-3.51%ADVB+13.11%
Niche Market Leaders Execute Buybacks and AI Pivots in Late 2026Global Report·Jul 24 at 04:13 AMFTAI-0.38%DOX+2.46%
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focusrttnews·Jul 23 at 10:24 PMNVCR-11.71%MEDP-0.73%
NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving RecoveryTradingKey·Jul 23 at 09:01 PMNVCR-11.71%
Crude Oil Rises Sharply; T-Mobile Shares Fall Following Q2 Resultsbenzinga_article·Jul 23 at 12:31 PMCLF+8.85%ACI-2.13%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 23 at 12:05 PMNUWE-6.82%ZYBT-3.89%
NovoCure (NASDAQ:NVCR) Posts Quarterly Earnings Results, Beats Estimates By $0.20 EPSMarket Beat·Jul 23 at 10:11 AMNVCR-11.71%
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursdaybenzinga_article·Jul 23 at 09:20 AMNVCR-11.71%LMT+2.46%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC-80.82%HYFT+15.25%
Novocure Q2 FY26 net loss narrows to USD 15.66 million; revenue rises 16% to USD 183.58 millionPUBT·Jul 23 at 06:01 AMNVCR-11.71%
